Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer
Cell2017Vol. 171(3), pp. 696–709.e23
Citations Over TimeTop 10% of 2017 papers
Liron Bar‐Peled, Esther K. Kemper, Radu M. Suciu, Ekaterina V. Vinogradova, Keriann M. Backus, Benjamin D. Horning, Thomas A. Paul, Taka-Aki Ichu, Robert Svensson, José Olucha, Max W. Chang, Bernard P. Kok, Zhou Zhu, Nathan T. Ihle, Melissa M. Dix, Ping Jiang, Matthew M. Hayward, Enrique Sáez, Reuben J. Shaw, Benjamin F. Cravatt
Related Papers
- → Structure-based assessment and druggability classification of protein–protein interaction sites(2022)41 cited
- → Druggability of the enzymes of the non-mevalonate-pathway(2013)61 cited
- → Druggability analysis and classification of protein tyrosine phosphatase active sites(2016)51 cited
- → Network motifs modulate druggability of cellular targets(2016)13 cited
- → Druggability Prediction(2012)5 cited